164 related articles for article (PubMed ID: 8698064)
1. Standardized uptake values of fluorine-18 fluorodeoxyglucose: the value of different normalization procedures.
Schomburg A; Bender H; Reichel C; Sommer T; Ruhlmann J; Kozak B; Biersack HJ
Eur J Nucl Med; 1996 May; 23(5):571-4. PubMed ID: 8698064
[TBL] [Abstract][Full Text] [Related]
2. Dependency of standardized uptake values of fluorine-18 fluorodeoxyglucose on body size: comparison of body surface area correction and lean body mass correction.
Kim CK; Gupta NC
Nucl Med Commun; 1996 Oct; 17(10):890-4. PubMed ID: 8951911
[TBL] [Abstract][Full Text] [Related]
3. Within-patient variability of (18)F-FDG: standardized uptake values in normal tissues.
Paquet N; Albert A; Foidart J; Hustinx R
J Nucl Med; 2004 May; 45(5):784-8. PubMed ID: 15136627
[TBL] [Abstract][Full Text] [Related]
4. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction.
Zasadny KR; Wahl RL
Radiology; 1993 Dec; 189(3):847-50. PubMed ID: 8234714
[TBL] [Abstract][Full Text] [Related]
5. Standardized uptake value and quantification of metabolism for breast cancer imaging with FDG and L-[1-11C]tyrosine PET.
Kole AC; Nieweg OE; Pruim J; Paans AM; Plukker JT; Hoekstra HJ; Schraffordt Koops H; Vaalburg W
J Nucl Med; 1997 May; 38(5):692-6. PubMed ID: 9170429
[TBL] [Abstract][Full Text] [Related]
6. Standardized uptake value in pediatric patients: an investigation to determine the optimum measurement parameter.
Yeung HW; Sanches A; Squire OD; Macapinlac HA; Larson SM; Erdi YE
Eur J Nucl Med Mol Imaging; 2002 Jan; 29(1):61-6. PubMed ID: 11807608
[TBL] [Abstract][Full Text] [Related]
7. Standardized uptake values of FDG: body surface area correction is preferable to body weight correction.
Kim CK; Gupta NC; Chandramouli B; Alavi A
J Nucl Med; 1994 Jan; 35(1):164-7. PubMed ID: 8271040
[TBL] [Abstract][Full Text] [Related]
8. Effect of corrections for blood glucose and body size on [18F]FDG PET standardised uptake values in lung cancer.
Hallett WA; Marsden PK; Cronin BF; O'Doherty MJ
Eur J Nucl Med; 2001 Jul; 28(7):919-22. PubMed ID: 11504091
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil.
Findlay M; Young H; Cunningham D; Iveson A; Cronin B; Hickish T; Pratt B; Husband J; Flower M; Ott R
J Clin Oncol; 1996 Mar; 14(3):700-8. PubMed ID: 8622014
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional clinical PET in lung cancer: validation and practical strategies.
Calvo R; Martí-Climent JM; Richter JA; Peñuelas I; Crespo-Jara A; Villar LM; García-Velloso MJ
J Nucl Med; 2000 Mar; 41(3):439-48. PubMed ID: 10716316
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive estimation of the net influx constant using the standardized uptake value for quantification of FDG uptake of tumours.
Sadato N; Tsuchida T; Nakaumra S; Waki A; Uematsu H; Takahashi N; Hayashi N; Yonekura Y; Ishii Y
Eur J Nucl Med; 1998 Jun; 25(6):559-64. PubMed ID: 9618569
[TBL] [Abstract][Full Text] [Related]
12. Role of Optimal Quantification of FDG PET Imaging in the Clinical Practice of Radiology.
Ziai P; Hayeri MR; Salei A; Salavati A; Houshmand S; Alavi A; Teytelboym OM
Radiographics; 2016; 36(2):481-96. PubMed ID: 26963458
[TBL] [Abstract][Full Text] [Related]
13. Differentiating benign from malignant lung lesions using "quantitative" parameters of FDG PET images.
Hübner KF; Buonocore E; Gould HR; Thie J; Smith GT; Stephens S; Dickey J
Clin Nucl Med; 1996 Dec; 21(12):941-9. PubMed ID: 8957608
[TBL] [Abstract][Full Text] [Related]
14. Lung cancer: reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucose uptake at PET.
Minn H; Zasadny KR; Quint LE; Wahl RL
Radiology; 1995 Jul; 196(1):167-73. PubMed ID: 7784562
[TBL] [Abstract][Full Text] [Related]
15. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
16. Breast imaging with fluorine-18-FDG PET: quantitative image analysis.
Avril N; Bense S; Ziegler SI; Dose J; Weber W; Laubenbacher C; Römer W; Jänicke F; Schwaiger M
J Nucl Med; 1997 Aug; 38(8):1186-91. PubMed ID: 9255146
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of CT-based SUV normalization.
Devriese J; Beels L; Maes A; Van de Wiele C; Pottel H
Phys Med Biol; 2016 Sep; 61(17):6369-83. PubMed ID: 27498994
[TBL] [Abstract][Full Text] [Related]
18. Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary results.
Sugawara Y; Braun DK; Kison PV; Russo JE; Zasadny KR; Wahl RL
Eur J Nucl Med; 1998 Sep; 25(9):1238-43. PubMed ID: 9724371
[TBL] [Abstract][Full Text] [Related]
19. Regional 2-[18F]fluoro-2-deoxy-D-glucose uptake varies in normal lung.
Miyauchi T; Wahl RL
Eur J Nucl Med; 1996 May; 23(5):517-23. PubMed ID: 8698055
[TBL] [Abstract][Full Text] [Related]
20. [18F]fluorodeoxyglucose uptake in tumors: kinetic vs. steady-state methods with reference to plasma insulin.
Minn H; Leskinen-Kallio S; Lindholm P; Bergman J; Ruotsalainen U; Teräs M; Haaparanta M
J Comput Assist Tomogr; 1993; 17(1):115-23. PubMed ID: 8419418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
